- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02895399
Epidemiology of Human Papillomavirus Infection Among Women Living on the Maroni and the Oyapock Rivers (EPHaVI)
Epidémiologie de l'Infection à Human Papilloma Virus Chez Les Femmes Vivant Sur Les Fleuves Maroni et Oyapock
Cervical cancer is the second most frequent cancer of women in French Guiana. Studies have shown that populations living in remote villages in the interior of the territory have early sexual relations and that multiple sexual partnerships are frequent. Hence, the main objective of the study was to determine the prevalence of HPV in these areas, and the predictive factors and epidemiology of this viral infection.
Methods - This multicentric cross sectional study aimed the population of women aged 20 to 65 years, living in the remote villages along the Maroni and Oyapock rivers. Women wishing to participate will be included after being informed of the study team schedule through radio address and key opinion leaders. The search for HPV and cytologic examinations will be performed for each woman. 2 samples will be taken from each woman: one sample will be sent to Fort De France hospital for cytology, and HPV testing; cytologic analyses will be performed using the 2001 Bethesda classification. Another sample will be sent to Pasteur Institute in Cayenne for sequencing and detection of E6 and E7 RNA which are associated with carcinogenesis. HPV infection will be defined by the detection of viral DNA using the GREINER-BIO-ONE kit. Statistical analysis of the results will use STATA software and mapping will use Mapinfo.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Women aged from 20 to 65 living in a common Maroni rivers (Apatou , Grand Santi, Papaichton , Maripasoula and the Native American territory of Upper Maroni) and / or Oyapock ( Saint Georges, Camopi , Three Jumps )
- Having already had sexual intercourse
- Having given after information , consent to the inclusion in the study
Exclusion Criteria:
- Age < 20 or age> 65 years
- Being pregnant more than 3 months
- Have had a hysterectomy
- Denial of participation
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Prevalence and distribution of Human Papillomaviruses genotypes
Time Frame: At the time of inclusion (baseline)
|
At the time of inclusion (baseline)
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 30814
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Human Papillomavirus Viruses
-
University of CincinnatiActive, not recruitingPapillomavirus Vaccines | Human Papillomavirus VirusesUnited States
-
The Behavioural Insights TeamUNICEF; National Center for Disease Control and Public Health, Georgia; Information...Not yet recruitingHPV, Human Papillomavirus Viruses, Human Papilloma Virus Vaccine
-
Shanghai East HospitalRecruitingMesenchymal Stem Cells | Human Papillomavirus VirusesChina
-
M.D. Anderson Cancer CenterRecruitingHuman PapillomavirusUnited States
-
Kaiser PermanenteNational Cancer Institute (NCI)Recruiting
-
Université de Reims Champagne-ArdenneCompletedHuman PapillomavirusFrance
-
Queen Mary University of LondonCompleted
-
Lake Cumberland District Health DepartmentMerck Sharp & Dohme LLCCompletedHuman PapillomavirusUnited States
-
The University of Hong KongQueen Mary Hospital, Hong KongUnknown
-
Global Alliance to Immunize Against AIDS Vaccine...Merck Sharp & Dohme LLCUnknownHuman PapillomavirusMali
Clinical Trials on Cervico-Vaginal Smears analysis
-
Assistance Publique Hopitaux De MarseilleTerminatedCervical Intraepithelial NeoplasiaFrance
-
Queen Mary University of LondonCompleted
-
Centre Hospitalier Universitaire de Saint EtienneRecruiting
-
GlaxoSmithKlineCompletedInfections, PapillomavirusGermany, Poland
-
University of WashingtonMinnesota Ovarian Cancer AllianceTerminatedStage III Ovarian Cancer AJCC v8 | Stage IIIA Ovarian Cancer AJCC v8 | Stage IIIA1 Ovarian Cancer AJCC v8 | Stage IIIA2 Ovarian Cancer AJCC v8 | Stage IIIB Ovarian Cancer AJCC v8 | Stage IIIC Ovarian Cancer AJCC v8 | Stage IV Ovarian Cancer AJCC v8 | Stage IVA Ovarian Cancer AJCC v8 | Stage IVB Ovarian... and other conditionsUnited States
-
Centre Hospitalier Universitaire de NīmesCompletedVaginal LesionFrance
-
Assistance Publique - Hôpitaux de ParisCompletedExtrapulmonary TuberculosisFrance
-
Centre Hospitalier Universitaire, AmiensRecruitingInfertility | Endometriosis | Epigenetics | Gut Microbiota | Vaginal Microbiota | Pesticides | Cell Free DNA | Female Fertility | Genital Microbiota | Endometrial MicrobiotaFrance
-
Poitiers University HospitalUnknown
-
Catharina Ziekenhuis EindhovenZonMw: The Netherlands Organisation for Health Research and Development; Stichting... and other collaboratorsRecruitingCervical Intraepithelial Neoplasia | CIN 2/3 | Cervical Intraepithelial Neoplasia Grade 2/3 | Cervical High Grade Squamous Intraepithelial LesionNetherlands